Skip to content
10-K

Annual Report

KALEIDO BIOSCIENCES, INC.

0001564590-21-010420

← back to feed
Filed
Mar 3, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Feb 26, 2021 42.47M sh
Capex FY 2020 · Dec 31, 2019 $3.59M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$75.8M
Long Term Debt FY 2020 · Dec 31, 2019 $20.39M
Cash And Equivalents FY 2020 · Dec 31, 2019 $71.24M
Current Liabilities FY 2020 · Dec 31, 2019 $10.38M
Total Liabilities FY 2020 · Dec 31, 2019 $33.42M
Current Assets FY 2020 · Dec 31, 2019 $73.28M
Total Assets FY 2020 · Dec 31, 2019 $82.31M
Sga Expense FY 2020 · Dec 31, 2019 $22.43M
Rd Expense FY 2020 · Dec 31, 2019 $64.23M
Net Income FY 2020 · Dec 31, 2019 −$86.33M
Operating Income FY 2020 · Dec 31, 2019 −$86.66M
Stockholders Equity FY 2020 · Dec 31, 2018 −$96.24M